Overview

Remote Patient Monitoring (RPM) Market is poised to register a CAGR of 26.7% during the forecast period 2022 to 2028.

Digital technologies are used to convey medical and other sorts of health data, such as clinical data, patient registry, and patient current health status, to a healthcare professional during remote patient monitoring. By gathering the data at the patient's home, money can be saved on care and hospitalisation. The expansion of the remote patient monitoring market share is driven by the growing elderly population and increase in disposable income. Due to the rapidly expanding global population and rise in the prevalence of chronic diseases, there has been an increase in the need to upgrade the healthcare infrastructure, as well as the cost-savings advantages of telehealth and the use of remote patient monitoring technology. The prevalence of lifestyle disorders, increased use of remote patient monitoring devices, and an increase in the number of elderly people are what are driving the expansion of the remote patient monitoring market size. The ease of use and accessibility of remote patient monitoring equipment is helping it become more and more popular. Additionally, elderly people use remote patient devices because they are more likely to have chronic illnesses than younger people. The market is anticipated to grow as a result of the rise in demand for tools used for at-home remote patient monitoring.

Global demand for these systems will rise in the coming years due to the improved chronic illness management offered by remote monitoring systems, together with early warning indicators and progress trackers. As the telemedicine software aids in digitising and automating crucial tasks, which minimises hospital administrative work and expands the use of Remote Patient Monitoring in the coming years, it can prevent ER visits and hospitalizations.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Remote Patient Monitoring (RPM) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Remote Patient Monitoring (RPM) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Remote Patient Monitoring (RPM) Market:
• BioTelemetry Inc.
• Koninklijke Philips N.V.
• Medtronic
• GE Healthcare
• Cerner Corporation
• Siemens Healthineers AG Germany
• OMRON Healthcare
• Boston Scientific Corporation
• Abbott Laboratories
• Resideo Life Care Solutions
• Vivify Health, Inc.
• ALTEN Calsoft Labs
• Preventice Solutions
• Bio-Beat Technologies
• VitalConnect
• Welch Allyn
• Teladoc Health Inc.
• Dexcom Inc.
• iRhythm Technologies, Inc.
• VivaLNK Inc. (US).
(Note: The list of the major players will be updated with the latest market scenario and trends)

Remote Patient Monitoring (RPM) Market Segmentation:
By Type
• Services & Software
• Devices
   o Cardiac Monitoring Devices
   o Neurological Monitoring Devices
   o Respiratory Monitoring Devices
   o Multiparameter Monitoring Devices
   o Blood Glucose Monitoring Devices
   o Fetal & Neonatal Monitoring Devices
   o Weight Monitoring Devices
   o Other Monitoring Devices

By Application
• Cancer Treatment
• Cardiovascular Diseases Treatment
• Diabetes Treatment
• Sleep Disorder Treatment
• Weight Management and Fitness Monitoring

By End User
• Providers
   o Hospitals and Clinics
   o Home Care Settings and Long Term Care Centers
   o Ambulatory Care Centers
• Payers
• Patients
• Other End Users

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Remote Patient Monitoring (RPM) Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Remote Patient Monitoring (RPM) Market By Type, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Remote Patient Monitoring (RPM) Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Remote Patient Monitoring (RPM) Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Remote Patient Monitoring (RPM) Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Remote Patient Monitoring (RPM) Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Services & Software
   7.2. Devices
        7.2.1. Cardiac Monitoring Devices
        7.2.2. Neurological Monitoring Devices
        7.2.3. Respiratory Monitoring Devices
        7.2.4. Multiparameter Monitoring Devices
        7.2.5. Blood Glucose Monitoring Devices
        7.2.6. Fetal & Neonatal Monitoring Devices
        7.2.7. Weight Monitoring Devices
        7.2.8. Other Monitoring Devices

8. Remote Patient Monitoring (RPM) Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Cancer Treatment
   8.2. Cardiovascular Diseases Treatment
   8.3. Diabetes Treatment
   8.4. Sleep Disorder Treatment
   8.5. Weight Management and Fitness Monitoring

9. Remote Patient Monitoring (RPM) Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Providers
        9.1.1. Hospitals and Clinics
        9.1.2. Home Care Settings and Long Term Care Centers
        9.1.3. Ambulatory Care Centers
   9.2. Payers
   9.3. Patients
   9.4. Other End Users

10. North America Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Remote Patient Monitoring (RPM) Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   16.1. BioTelemetry Inc.
         16.1.1. Company Overview
         16.1.2. Product Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
   16.2. Koninklijke Philips N.V.
         16.2.1. Company Overview
         16.2.2. Product Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
   16.3. Medtronic
         16.3.1. Company Overview
         16.3.2. Product Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
   16.4. GE Healthcare
         16.4.1. Company Overview
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
   16.5. Cerner Corporation
         16.5.1. Company Overview
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview          
   16.6. Siemens Healthineers AG Germany
         16.6.1. Company Overview
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview      
   16.7. OMRON Healthcare
         16.7.1. Company Overview
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
   16.8. Boston Scientific Corporation
         16.8.1. Company Overview
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
   16.9. Abbott Laboratories
         16.9.1. Company Overview
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
   16.10. Resideo Life Care Solutions
         16.10.1. Company Overview
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
   16.11. Vivify Health, Inc.
         16.11.1. Company Overview
         16.11.2. Product Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview
   16.12. ALTEN Calsoft Labs
         16.12.1. Company Overview
         16.12.2. Product Portfolio
         16.12.3. SWOT Analysis
         16.12.4. Financial Overview
         16.12.5. Strategic Overview
   16.13. Preventice Solutions
         16.13.1. Company Overview
         16.13.2. Product Portfolio
         16.13.3. SWOT Analysis
         16.13.4. Financial Overview
         16.13.5. Strategic Overview
   16.14. Bio-Beat Technologies
         16.14.1. Company Overview
         16.14.2. Product Portfolio
         16.14.3. SWOT Analysis
         16.14.4. Financial Overview
         16.14.5. Strategic Overview
   15.15. VitalConnect
         16.15.1. Company Overview
         16.15.2. Product Portfolio
         16.15.3. SWOT Analysis
         16.15.4. Financial Overview
         16.15.5. Strategic Overview
   16.16. Welch Allyn
         16.16.1. Company Overview
         16.16.2. Product Portfolio
         16.16.3. SWOT Analysis
         16.16.4. Financial Overview
         16.16.5. Strategic Overview
   16.17. Teladoc Health Inc.
         16.17.1. Company Overview
         16.17.2. Product Portfolio
         16.17.3. SWOT Analysis
         16.17.4. Financial Overview
         16.17.5. Strategic Overview
   16.18. Dexcom Inc.
         16.18.1. Company Overview
         16.18.2. Product Portfolio
         16.18.3. SWOT Analysis
         16.18.4. Financial Overview
         16.18.5. Strategic Overview
   16.19. iRhythm Technologies, Inc.
         16.19.1. Company Overview
         16.19.2. Product Portfolio
         16.19.3. SWOT Analysis
         16.19.4. Financial Overview
         16.19.5. Strategic Overview
   16.20. VivaLNK Inc
         16.20.1. Company Overview
         16.20.2. Product Portfolio
         16.20.3. SWOT Analysis
         16.20.4. Financial Overview
         16.20.5. Strategic Overview

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures